CytoMed Financial Statements From 2010 to 2026

CytoMed Therapeutics Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 5.5 M 8.5 M 3.7 M Slightly volatile Short and Long Term Debt Total 290 K 305.3 K 827.5 K Pretty Stable Other Current Liabilities 331.9 K 439.6 K 276.9 K Slightly volatile Total Current Liabilities 379.8 K 399.8 K 699.5 K Slightly volatile Total Stockholder Equity 7.9 M 7.5 M 2.8 M Slightly volatile Net Tangible Assets 485.8 K 511.4 K 1.4 M Slightly volatile Property Plant And Equipment Net 2 M 2.7 M 1.9 M Slightly volatile Accounts Payable 21.2 K 32.5 K 14.8 K Slightly volatile Cash 2.6 M 4.2 M 1.4 M Slightly volatile Non Current Assets Total 2.3 M 3.4 M 2 M Slightly volatile Cash And Short Term Investments 2.7 M 4.2 M 1.4 M Slightly volatile Net Receivables 15 K 15.8 K 32.3 K Slightly volatile Good Will 212 234 260 Slightly volatile Common Stock Shares Outstanding 8.9 M 13.3 M 7.1 M Slightly volatile Short Term Investments 241.9 K 230.4 K 82.4 K Slightly volatile Liabilities And Stockholders Equity 5.5 M 8.5 M 3.7 M Slightly volatile Non Current Liabilities Total 308.1 K 275 K 416.3 K Slightly volatile Inventory 384.3 K 706.3 K 206.2 K Slightly volatile Other Current Assets 219.2 K 145.4 K 108 K Slightly volatile Total Liabilities 641 K 674.8 K 1.1 M Slightly volatile Total Current Assets 3.3 M 5.1 M 1.8 M Slightly volatile Short Term Debt 28.7 K 30.3 K 413.9 K Slightly volatile Intangible Assets 82 K 78.1 K 33.7 K Slightly volatile Common Stock 21 M 20 M 6.6 M Slightly volatile Property Plant Equipment 2.6 M 2.8 M 2.4 M Slightly volatile Current Deferred Revenue 131.8 K 125.5 K 38.4 K Slightly volatile Long Term Debt 384.1 K 354.9 K 532.1 K Slightly volatile Capital Lease Obligations 17 K 28.2 K 27.2 K Slightly volatile Net Invested Capital 7.7 M 10.8 M 5.2 M Slightly volatile Property Plant And Equipment Gross 4 M 5.8 M 3.3 M Slightly volatile Short and Long Term Debt 32.2 K 33.9 K 1.9 M Slightly volatile Capital Stock 14.6 M 27.4 M 8.4 M Slightly volatile
CytoMed Therapeutics Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 136.6 K 82.4 K 124.6 K Slightly volatile Other Operating Expenses 3.2 M 3.1 M 1.1 M Slightly volatile Research Development 1 M 1.6 M 663.5 K Slightly volatile Total Operating Expenses 1.4 M 2.2 M 893.9 K Slightly volatile Interest Expense 13 K 13.7 K 66.8 K Slightly volatile Selling General Administrative 1.5 M 1.4 M 389.8 K Slightly volatile Selling And Marketing Expenses 15.3 K 27.3 K 10 K Slightly volatile Total Revenue 56.8 K 59.8 K 76.9 K Slightly volatile Cost Of Revenue 24.8 K 26.1 K 11.7 K Slightly volatile Reconciled Depreciation 381 K 385.7 K 319 K Slightly volatile Minority Interest 6.2 K 5.9 K 1.2 K Slightly volatile
CytoMed Therapeutics Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Begin Period Cash Flow 5.7 M 5.4 M 1.6 M Slightly volatile Depreciation 261.4 K 282.4 K 185.7 K Slightly volatile Capital Expenditures 1.2 M 1.2 M 775.7 K Pretty Stable End Period Cash Flow 2.2 M 4 M 1.2 M Slightly volatile Change To Netincome 1.5 M 1.4 M 466.7 K Slightly volatile Change To Liabilities 177.3 K 293.3 K 121 K Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 358 679 486 Pretty Stable PTB Ratio 6.53 6.87 19.6088 Very volatile Days Sales Outstanding 77.22 86.87 94.8163 Slightly volatile Book Value Per Share 0.27 0.52 0.3016 Slightly volatile Average Payables 23.4 K 27 K 23.7 K Pretty Stable Capex To Depreciation 2.71 4.8 4.8106 Slightly volatile PB Ratio 6.53 6.87 19.6088 Very volatile EV To Sales 349 622 499 Slightly volatile Inventory Turnover 0.0413 0.0333 0.0309 Slightly volatile Days Of Inventory On Hand 8.4 K 8.9 K 20.6 K Very volatile Payables Turnover 1.39 0.72 0.7792 Slightly volatile Sales General And Administrative To Revenue 22.57 21.49 6.0567 Slightly volatile Average Inventory 250.4 K 337.6 K 278 K Slightly volatile Research And Ddevelopement To Revenue 25.96 24.73 16.9446 Very volatile Capex To Revenue 18.63 17.74 6.2876 Slightly volatile Cash Per Share 0.21 0.28 0.1526 Slightly volatile Days Payables Outstanding 496 522 1.5 K Pretty Stable Income Quality 0.58 0.97 0.7447 Very volatile Intangibles To Total Assets 0.0079 0.0106 0.0102 Slightly volatile Current Ratio 9.35 8.9 3.4739 Slightly volatile Tangible Book Value Per Share 0.26 0.51 0.2966 Slightly volatile Receivables Turnover 3.02 3.4 3.7144 Slightly volatile Shareholders Equity Per Share 0.27 0.51 0.3008 Slightly volatile Debt To Equity 0.0564 0.0594 1.0823 Pretty Stable Capex Per Share 0.0713 0.1 0.1162 Slightly volatile Revenue Per Share 0.0039 0.0041 0.0096 Pretty Stable Interest Debt Per Share 0.0336 0.0353 0.1292 Pretty Stable Debt To Assets 0.0503 0.0529 0.2707 Very volatile Operating Cycle 8.5 K 9 K 20.6 K Very volatile Price Book Value Ratio 6.53 6.87 19.6088 Very volatile Days Of Payables Outstanding 496 522 1.5 K Pretty Stable Ebt Per Ebit 1.25 0.83 1.2216 Slightly volatile Company Equity Multiplier 1.23 1.29 2.3068 Pretty Stable Long Term Debt To Capitalization 0.046 0.0484 0.2187 Slightly volatile Total Debt To Capitalization 0.0537 0.0565 0.2988 Very volatile Debt Equity Ratio 0.0564 0.0594 1.0823 Pretty Stable Quick Ratio 8.04 7.66 3.0898 Slightly volatile Net Income Per E B T 1.12 1.15 1.0464 Pretty Stable Cash Ratio 7.74 7.37 2.7853 Slightly volatile Cash Conversion Cycle 8.1 K 8.6 K 19.1 K Very volatile Days Of Inventory Outstanding 8.4 K 8.9 K 20.6 K Very volatile Days Of Sales Outstanding 77.22 86.87 94.8163 Slightly volatile Free Cash Flow Operating Cash Flow Ratio 1.72 1.74 2.2624 Slightly volatile Price To Book Ratio 6.53 6.87 19.6088 Very volatile Fixed Asset Turnover 0.0187 0.0196 0.0447 Slightly volatile Debt Ratio 0.0503 0.0529 0.2707 Very volatile Price Sales Ratio 358 679 486 Pretty Stable Asset Turnover 0.0077 0.0081 0.0162 Very volatile Gross Profit Margin 0.84 0.91 0.9705 Slightly volatile Price Fair Value 6.53 6.87 19.6088 Very volatile
CytoMed Therapeutics Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 50.2 M 45.1 M 50.8 M Slightly volatile Enterprise Value 44.9 M 41.3 M 44.7 M Slightly volatile

CytoMed Fundamental Market Drivers

CytoMed Upcoming Events

About CytoMed Therapeutics Financial Statements

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether CytoMed Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CytoMed Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cytomed Therapeutics Limited Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cytomed Therapeutics Limited Stock:

How To Invest In CytoMed Details

Is CytoMed Stock a good investment? Details

What is CytoMed Therapeutics' Net Worth? Details

Largest Biotechnology Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details